Top Stories
-
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Topic
-
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Topic
-
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Topic
-
On Sunday, Oct. 6, cancer survivors, researchers, and physicians will cycle through the Hudson Valley to help Columbia solve cancer.
Topic
Latest News
- April 14, 2015
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
- March 26, 2015
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Topic
- March 19, 2015
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
Topic
- March 16, 2015
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
Topic
- March 12, 2015
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
Topic
- February 26, 2015
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.
Topic
- February 23, 2015
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
Topic
- February 19, 2015
An article in Cancer Today describes how the film based on Siddhartha Mukherjee's book came about.
Topic
- February 9, 2015
The drug Gleevec is well known not only for its effectiveness against leukemia. A similar drug might be able to tame some brain cancers, new research from Columbia University Medical Center has shown.
Topic
